The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.

The FDA has granted Visby Medical authorization to market their at-home, over-the-counter diagnostic test that detects ...

The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...

For all treated chlamydia infections, 14.0% of patients received doxycycline—the CDC's recommended treatment—alone or with ...

Chlamydia trachomatis is the most prevalent ... Ears: Patent canal, gray Tempanic Membrane (TM) with positive light reflex. Nose: Patent. Mouth: Palate intact, moist pink mucous membranes ...

Sanofi will soon commence a Phase I/II trial with its vaccine candidate to start generating immunogenicity data.

The US Food and Drug Administration (FDA) today approved the first at-home, over-the-counter test for chlamydia, gonorrhea, and trichomoniasis.

If you're sexually active, the Centers for Disease Control and Prevention recommend that you get tested for chlamydia and other sexually transmitted diseases once a year. If you test positive for ...

Prompt treatment of chlamydia and gonorrhea following a confirmed diagnosis is essential to prevent complications and reduce ...

The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and trichomoniasis in females. The so-called Visby Medical Women's ...

Thirty-five to 50% of infants born to mothers who test positive for clamydia develop chlamydial conjunctivitis, and 11 to 20% of these children develop pneumonia. [3] The initial watery mucoid ...